Dana-Farber Clinical Pathways provides physicians with best practices for cancer treatment from the medical center’s oncologists. From within the Philips IntelliSpace Oncology Platform — a precision medicine tool that integrates radiology, pathology, genomics and EHR data — Dana-Farber Clinical Pathways will help physicians match cancer patients to appropriate treatment options.
Dana-Farber and Philips will update the clinical pathways several times a year to reflect changing cancer treatments and guidelines.
“Cancer medicine is changing rapidly, and physicians are tasked with interpreting massive amounts of new information generated from publications and clinical trials,” Laurie H. Glimcher, MD, CEO of Dana-Farber, said in a May 31 statement. “Our clinical pathways provide physicians with the most current, evidence-based best practices so that all patients may be treated with the same high standard of care.”
More articles on data analytics & precision medicine:
Cleveland Clinic to open 21k-square-foot biobank
Provider Data Action Alliance releases road map for trustworthy provider data
NIH seeks genome centers to sequence data from 200k ‘All of Us’ participants per year: 4 things to know
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
